{"id":"W4403831401","doi":"10.1681/asn.2024c9ebnjqe","title":"NeflgArd Open-Label Extension: Efficacy and Safety of Nefecon in Patients with IgAN Who Completed the 2-Year Phase 3 Trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Open label; Medicine; Extension (predicate logic); Internal medicine; Clinical trial; Intensive care medicine; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006658794,0.0001483561,0.000678057,0.0000520027,0.0001479969,0.00001352564,0.0006126693,0.00008513687,0.00003600648],"category_scores_gemma":[0.00004922511,0.00007867882,0.0001662423,0.0003727793,0.001952303,0.00009480201,0.0002115716,0.0005570226,0.000001820965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002342702,"about_ca_system_score_gemma":0.0001341328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001110621,"about_ca_topic_score_gemma":0.000002610757,"domain_scores_codex":[0.9984797,0.0004186628,0.0006365557,0.000159039,0.00007694233,0.0002290801],"domain_scores_gemma":[0.9983777,0.0004086964,0.0007967195,0.000280727,0.0001284353,0.000007711259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.369781,0.008160313,0.004113893,0.0001471765,0.004977521,0.00001186832,0.01605836,0.0002414454,0.3843584,0.001019302,0.03139726,0.1797334],"study_design_scores_gemma":[0.3458193,0.02832001,0.4985099,0.0006221267,0.0007126383,0.0002191167,0.007026213,0.0002392577,0.001532843,0.0004048165,0.1160876,0.0005061567],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921393,0.004313428,0.00004201866,0.002745276,0.000274397,0.0004159275,0.00001771137,0.000004565859,0.00004732755],"genre_scores_gemma":[0.998252,0.0002792728,0.00006987865,0.001313853,0.000009735995,0.000002229769,0.000005052349,0.00001254374,0.00005538565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.494396,"threshold_uncertainty_score":0.7193344,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01826898132791963,"score_gpt":0.2822031869615203,"score_spread":0.2639342056336006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}